Zhang Jie, chairman of MicroPort NeuroScience, said the division of labor is clear: MicroPort NeuroScience is responsible for the brain side, undertaking the overall system construction of BCI technology, from product design to clinical verification, while OYMotion handles the limb side. The collaboration will focus on software-hardware adaptation, signal transmission, and user experience optimization, with application scenarios centered on medical rehabilitation and expanding human-machine interaction boundaries. Zhang Qi, director and vice president of OYMotion, said the BCI industry has completed its first development phase and is entering the eve of deployment, with attention shifting to the integration of technology with scenarios, technology with technology, and technology with business.
OYMotion and MicroPort NeuroScientific Partner on Endovascular BCI Rehab System
Summary
OYMotion and MicroPort NeuroScientific signed a strategic cooperation agreement on May 28, 2026 to jointly develop an interventional brain-computer interface rehabilitation system. The first product will be a multi-channel endovascular BCI that threads a signal-recording stent through the blood vessels to a target brain region, capturing intracranial electrical activity without opening the skull. MicroPort NeuroScientific will build the BCI system as a whole and OYMotion the limb side, with the pair targeting medical rehabilitation and human-machine interaction.
Why it matters
The endovascular route Synchron pioneered is now being assembled in China out of parts that already exist: a neurointerventional device maker brings the stent and the vascular delivery path, a myoelectric prosthetics maker brings the hand. That division of labor is a shorter road to a product than either firm building the other half itself.
Compiled by BCIwiki from public sources